QNRX QUOIN PHARMACEUTICALS LTD Product Launches 8-K Filing 2025 - Positive Clinical Data Quoin Pharmaceuticals Ltd reported positive clinical results from its Pediatric Netherton Syndrome study, showing significant improvements in skin healing and itch reduction after two weeks of treatment with QRX003, with no adverse events reported.Get access to all SEC 8-K filings of the QUOIN PHARMACEUTICALS LTD